Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.
View the full Corporate Spotlight
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $1.18 | Day High | $1.19 | Day Low | $1.16 | |||
| Daily Volume | 65430 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 4 | $1.17 | 20389 | 4 | $1.20 | 6324 | |
| Dr. Sophia Moscovis | Vice President of Operations and Strategy |
| Dr. Serge Scrofani | Non-Executive Director |
| Mr. Brendan Brown | Chief Financial Officer |
| Dr. Daniel Tillett | Chief Executive Officer, Managing Director |
| Dr Megan Baldwin | Non-Executive Director |
| Dr. Peter Smith | Executive Chairman of the Board |
| Dr. Simon Fisher | Vice President - Clinical |
| Prof. Michael Kelso | Vice President - Research |
| Dr. Marinella Messina | Vice President - Clinical Development |
| Dr. Jose Iglesias | Chief Medical Officer |
| Mr. Peter Gordon Webse | Company Secretary |
Data source: Refinitiv
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
-0.010(0.84%) |
Mkt cap ! $204.1M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.19 | $1.16 | $76.76K | 65.43K |
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 20389 | $1.17 |
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 6324 | 4 |
| Last trade - 15.57pm 30/07/2025 (20 minute delay) ? |
|
|||||
|
Last
$1.18 |
Change
-0.010 ( 0.84 %) |
||||
| Open | High | Low | Volume | ||
| $1.18 | $1.18 | $1.16 | 9257 | ||
| Last updated 15.57pm 30/07/2025 ? | |||||
| RAC (ASX) Chart |
